Notice: file_put_contents(): Write of 12890 bytes failed with errno=28 No space left on device in /var/www/tgoop/post.php on line 50

Warning: file_put_contents(): Only 4096 of 16986 bytes written, possibly out of free disk space in /var/www/tgoop/post.php on line 50
کمیتهٔ تحقیقات و فناوری دانشجویی | د ع پ بیرجند@srcbums P.3373
SRCBUMS Telegram 3373
Forwarded from CGC2026
🔹Key Speaker of CGC2024
🔸Dr. Vahid Khoddami

Vahid Khoddami is the founder and CEO of ReNAP Therapeutics. Khoddami received his BSc in Medical laboratory sciences from Tehran University of Medical Sciences, his MSc in medical biotechnology from Tarbiat Modarres University and his PhD in Oncological Sciences from University of Utah (Cairns lab; HHMI, Department of Oncological Sciences). He then served as postdoctoral fellow for one year at the Huntsman Cancer Institute, Utah, then moved to Boston to spend three more years as postdoctoral fellow at Harvard Medical School (Moazed lab; HHMI, Department of Cell Biology). Eventually following ten years of study and research in United States, in the field of epigenomics and epitrascriptomics with emphasis on RNA modification studies, Khoddami returned to Iran in 2017, and in 2019 he founded ReNAP Therapeutics, a leading company in the field of mRNA technology in Iran and the region.

🌐 WWW.ICGCS.COM
🔺 T.me/icgcs          
🔺 instagram.com/icgcs



tgoop.com/srcbums/3373
Create:
Last Update:

🔹Key Speaker of CGC2024
🔸Dr. Vahid Khoddami

Vahid Khoddami is the founder and CEO of ReNAP Therapeutics. Khoddami received his BSc in Medical laboratory sciences from Tehran University of Medical Sciences, his MSc in medical biotechnology from Tarbiat Modarres University and his PhD in Oncological Sciences from University of Utah (Cairns lab; HHMI, Department of Oncological Sciences). He then served as postdoctoral fellow for one year at the Huntsman Cancer Institute, Utah, then moved to Boston to spend three more years as postdoctoral fellow at Harvard Medical School (Moazed lab; HHMI, Department of Cell Biology). Eventually following ten years of study and research in United States, in the field of epigenomics and epitrascriptomics with emphasis on RNA modification studies, Khoddami returned to Iran in 2017, and in 2019 he founded ReNAP Therapeutics, a leading company in the field of mRNA technology in Iran and the region.

🌐 WWW.ICGCS.COM
🔺 T.me/icgcs          
🔺 instagram.com/icgcs

BY کمیتهٔ تحقیقات و فناوری دانشجویی | د ع پ بیرجند




Share with your friend now:
tgoop.com/srcbums/3373

View MORE
Open in Telegram


Telegram News

Date: |

How to build a private or public channel on Telegram? How to create a business channel on Telegram? (Tutorial) Telegram message that reads: "Bear Market Screaming Therapy Group. You are only allowed to send screaming voice notes. Everything else = BAN. Text pics, videos, stickers, gif = BAN. Anything other than screaming = BAN. You think you are smart = BAN. Users are more open to new information on workdays rather than weekends. In 2018, Telegram’s audience reached 200 million people, with 500,000 new users joining the messenger every day. It was launched for iOS on 14 August 2013 and Android on 20 October 2013.
from us


Telegram کمیتهٔ تحقیقات و فناوری دانشجویی | د ع پ بیرجند
FROM American